Oxford BioMedica (LSE:OXB) Short Interest


LSE:OXB Oxford BioMedica PLC LSE:OXB
68 GF Score
Price £6.34
GF Value £5.36
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Oxford BioMedica Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LSE:OXB vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Oxford BioMedica's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford BioMedica Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioMedica's Short Interest distribution charts can be found below:

* The bar in red indicates where Oxford BioMedica's Short Interest falls into.


LSE:OXB
68GF Score
Oxford BioMedica PLC LSE:OXB
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Oxford BioMedica (LSE:OXB) Overvalued in 2026?

Based on GuruFocus' analysis, Oxford BioMedica stock appears to be overvalued. The current stock price of £6.34 is trading 18.3% above its estimated GF Value™ of £5.36. GuruFocus considers Oxford BioMedica to be Modestly Overvalued.

Key valuation signals for LSE:OXB:

  • Short Interest:
  • GF Value™: £5.36 vs. price of £6.34 (18.3% above fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the LSE:OXB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oxford BioMedica Business Description

Other Exchanges OXBDF:USAOXBl:UKOXO:Germany
Address Transport Way, Windrush Court, Oxford, GBR, OX4 6LT
Oxford BioMedica PLC is a contract development and manufacturing organization (CDMO) focused on cell and gene therapy. The company specializes in viral vector development and manufacturing for cell and gene therapy, with expertise in lentivirus, adeno-associated virus (AAV), adenovirus, and other viral vector types. Geographically, it derives maximum revenue from the United States, and the rest from Europe, the UK, and the Rest of the world.
68GF Score

Get the complete analysis for LSE:OXB

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£6.34
Price
£5.36
GF Value